⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LXEO News
Lexeo Therapeutics, Inc. Common Stock
Gene Therapies for Cardiomyopathies Market Poised for Rapid Expansion During the Forecast Period (2025-2034) with Advancements in AAV and CRISPR Platforms | DelveInsight
prnewswire.com
LXEO
TNYA
RPTX
Lexeo Therapeutics to Host Virtual Key Opinion Leader Event at the 22nd Global Cardiovascular Clinical Trialists (CVCT) Forum
globenewswire.com
LXEO
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
globenewswire.com
LXEO
Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
globenewswire.com
LXEO
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
LXEO
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
prnewswire.com
GTBP
LXEO
ANIX
TEM
CTOR
GTBP
LXEO
ANIX
TEM
CTOR
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
globenewswire.com
LXEO